BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts.

Radiat Oncol · 2014 · PMC4262387 · PMID 25234922

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

only marginally significantp=0.09so close (0.05 < p ≤ 0.1)

This effect was only marginally significant (p=0.09) likely due to considerable intertumoral heterogeneity in response to RCT as suggested by shallow dose–response curve (Figure 4 b).

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.